Elixiron

Developer of immunotherapy for cancer and immunological diseases

placeTaipei, Taipei, Taiwan calendar_todayFounded 2016 groups23 employees language elixiron.com

Social engagement

Social engagement: 707 social following, 8 posts in the last 12 months — below the industry typical range.

Recent activity

12 Jan 2026
Milestone
Emerging Stock Board listing
6 Jan 2026
Milestone
regulatory
31 Dec 2025
Milestone
regulatory
Coming soon